Event Details

Cyclerion CNS Focused Webcast Investor Event

Jul 9, 2020 at 8:15 AM EDT

Supporting Materials

This webcast event will focus on IW-6463, the company’s investigational, orally administered, once-daily CNS-penetrant sGC stimulator designed for the treatment of serious CNS diseases. Cyclerion’s clinical and scientific leaders will discuss:

  • Potential to harness the nitric oxide/sGC system for treating serious CNS diseases
  • IW-6463 preclinical and Phase 1 clinical study data
  • Design of the ongoing IW-6463 translational pharmacology clinical study
  • Anticipated development directions for our potential CNS therapies

Joining us for the Webinar are two thought-leading CNS scientist/clinicians.  Focused on the CNS areas in which Cyclerion is working, they bring perspectives on the patients, the latest treatment practices and associated clinical trial approaches:

Marni J. Falk, M.D.
University of Pennsylvania, Professor of Human Genetics; The Children's Hospital of Philadelphia (CHOP) Director of the Mitochondrial Medicine Frontier Program

Eric Smith, MD, MPH, FRCuP(C), FAHA
University of Calgary and Hotchkiss Brain Institute, Associate Professor of Neurology, Katthy Taylor Chair in Vascular Dementia, Department of Clinical Neurosciences